Search Within

Azeez Farooki

  1. "Health Outcomes Research Group"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (5)
  2. Division of Subspecialty Medicine (5)
  3. Endocrinology (5)
  4. Epidemiology and Biostatistics (5)
  5. Genitourinary Oncology Service (5)
  6. Health Outcomes Research Group (5)

More Groups

People
  1. Aaron Mitchell (5)
  2. Michael Morris (5)
  3. Akriti Mishra (3)
  4. Sonia Persaud (3)
  5. Allison Lipitz Snyderman (2)
  6. Jamie Ostroff (2)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. JCO Oncology Practice (1)
  3. Prostate (1)
  4. Prostate Cancer and Prostatic Diseases (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. John Wiley & Sons (1)
  3. Nature Publishing Group (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Costs to Medicare of nonrecommended bone-modifying agent use for castration-sensitive prostate cancer
    Journal Article

    Mitchell, A. P.; Nemirovsky, D.; Mishra Meza, A.; Chakraborty, N.; Persaud, S.; Farooki, A.; Morris, M. J.
    JCO Oncology Practice (2024)

    Fulltext@MSK | Save
  • Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer
    Journal Article

    Mitchell, A. P.; Persaud, S.; Palyca, P.; Salner, A.; Farooki, A.; Ostroff, J. S.; Morris, M. J.; Chimonas, S.
    Prostate (2024)

    Fulltext@MSK | Save
  • Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Farooki, A.; Morris, M. J.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Barriers to guideline-concordant use of bone modifying agents for prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Persaud, S.; Chimonas, S.; Salner, A. L.; Palyca, P.; Farooki, A.; Ostroff, J. S.; Morris, M. J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Use of bone modifying agents for metastatic castrate-resistant prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Mishra Meza, A.; Farooki, A.; Panageas, K.; Bach, P. B.; Lipitz-Snyderman, A.; Morris, M. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save